Anaplastic thyroid cancer


DOI: https://dx.doi.org/10.18565/therapy.2022.6.83-91

Rasko D.V., Rudnitskaya M.A., Vertkin A.L.

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
Abstract. The article presents a clinical case of a patient with anaplastic thyroid cancer diagnosed in therapeutic hospital conditions. This example is intended to draw the attention of doctors of various specialities to the need for cancer alertness when detecting any neoplasms in the neck area. Careful examination of the patient according to protocols for the management of suspected thyroid malignancy allows a timely diagnosis to be made and appropriate treatment to be given, which significantly improves the prognosis for the patient’s life.

Literature


1. Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2020; 252 с. [Malignant neoplasms in Russia in 2019 (morbidity and mortality). Ed. by Kaprin A.D., Starinsky V.V., Petrova G.V. Moscow: MNIOI P.A. Herzen – a branch of the National Medical Research Center of Radiology. 2020; 252 pp. (In Russ.)]. ISBN: 978-5-85502-260-5.


2. Сычева А.С., Верткин А.Л., Кебина А.Л. Онкологическая настороженность у пациентов на амбулаторном терапевтическом этапе. Медицинский алфавит. 2021; 7: 41–45. [Sycheva A.S., Vertkin A.L., Kebina A.L. Oncological alertness in patients at outpatient therapeutic stage. Meditsinskiy alfavit = Medical Alphabet. 2021; 7: 41–45 (In Russ.)].https://dx.doi.org/10.33667/2078-5631-2021-7-41-45. EDN: BNCAQL.


3. Александрова Л.М., Старинский В.В., Каприн А.Д. с соавт. Профилактика онкологических заболеваний как основа взаимодействия онкологической службы с первичным звеном здравоохранения. Исследования и практика в медицине. 2017; 4(1): 74–80. [Aleksandrova L.M., Starinsky V.V., Kaprin A.D., Samsonov Yu.V. Prevention of oncological diseases as the basis of interaction of oncological service with primary link of health care. Issledovaniya i praktika v meditsine = Research’n Practical Medicine Journal. 2017; 4(1): 74–80 (In Russ.)]. https://dx.doi.org/10.17709/2409-2231-2017-4-1-10. EDN: YGFGKD.


4. Верткин А.Л., Румянцев М.А., Скотников А.С. Коморбидность в клинической практике. Часть 2. Архивъ внутренней медицины. 2011; 2: 20–24. [Vertkin A.L., Rumyantsev M.A., Skotnikov A.S. Comorbidities in clinical experience. Part 2. Arkhiv vnutrenney meditsiny = Archive of Internal Medicine. 2011; 2: 20–24 (In Russ.)]. https://dx.doi.org/10.20514/2226-6704-2011-0-2-20-24. EDN: RPELWZ.


5. Gilliland F.D., Hunt W.C., Morris D.M., Key C.R. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer. 1997; 79(3): 564–73.https://dx.doi.org/10.1002/(sici)1097-0142(19970201).


6. Smallridge R.C., Ain K.B., Asa S.L. et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012; 22(11): 1104–39. https://dx.doi.org/10.1089/thy.2012.0302.


7. Пылев А.Л., Жандарова А.А., Петров К.С. с соавт. Анапластический рак щитовидной железы. Есть ли свет в конце туннеля? Опухоли головы и шеи. 2020; 10(1): 10–19. [Pylev A.L., Zhandarova A.A., Petrov K.S. et al. Anaplastic thyroid cancer. Is there a light at the end of the tunnel? Opukholi golovy i shei = Head and Neck Tumors (HNT). 2020; 10(1): 10–19 (In Russ.)].https://dx.doi.org/10.17650/2222-1468-2020-10-1-10-19. EDN: ZWALOE.


8. Серегина И.Ф., Драпкина О.М., Колоколов А.В. с соавт. Проблемные вопросы качества проведения диспансеризации и профилактических медицинских осмотров взрослого населения и пути их решения. Вестник Росздравнадзора. 2020; 5–1: 51–59. [Seregina I.F., Drapkina O.M., Kolokolov A.V. et al. Quality issues of preventive and prophylactic medical examinations of adult population and feasible solutions. Vestnik Roszdravnadzora = Bulletin of Roszdravnadzor. 2020; 5–1: 51–59 (In Russ.)].https://dx.doi.org/10.35576/2070-7940-2020-5-1-51-59. EDN: QXNVEX.


9. Cibas E.S., Ali S.Z. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017; 27(11): 1341–46.https://dx.doi.org/10.1089/thy.2017.0500.


10. Клинические рекомендации. Рак щитовидной железы. Общероссийская общественная организация «Российское общество детских онкологов», Национальное общество детских гематологов, онкологов. Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 74. Доступ: https://cr.minzdrav.gov.ru/schema/74_1 (дата обращения – 01.08.2022). [Clinical guidelines. Thyroid cancer. Russian Society of Pediatric Oncologists, National Society of Pediatric Hematologists and Oncologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 74.URL: https://cr.minzdrav.gov.ru/schema/74_1 (date of access – 01.08.2022) (In Russ.)].


About the Autors


Dina V. Rasko, assistant at the Department of therapy, clinical pharmacology and emergency medicine, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia. Address: 127473, Moscow, 20/1 Delegatskaya Str. E-mail: disharasko@mail.ru
Maria A. Rudnitskaya, assistant at the Department of therapy, clinical pharmacology and emergency medicine, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia. Address: 127473, Moscow, 20/1 Delegatskaya Str. E-mail: bondar3011@rambler.ru
Arkady L. Vertkin, Dr. med. habil., professor, head of the Department of therapy, clinical pharmacology and emergency medicine, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia. Address: 127473, Moscow, 20/1 Delegatskaya Str. E-mail: kafedrakf@mail.ru.
ORCID: https://orcid.org/0000-0001-8975-8608


Similar Articles


Бионика Медиа